Suchergebnisse - "Zhan, Qi"

PubPharm (6)

1

Retraction of "Universal theranostic CRISPR/Cas13a RNA-editing system for glioma"

enthalten in: Theranostics | 2024

von Wu, Y. | Wang, Y. | Zhou, J. | +10

RetractionOf: Theranostics. 2023 Sep 25;13(15):5305-5321. - PMID 37908718

2

Universal theranostic CRISPR/Cas13a RNA-editing system for glioma

enthalten in: Theranostics | 2023

von Wu, Y. | Wang, Y. | Zhou, J. | +10

RetractionIn: Theranostics. 2024 Apr 6;14(6):2489. - PMID 38646655

3

TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma

enthalten in: Theranostics | 2022

von Yang, S. | Zhao, J. | Cui, X. | +8

4

Erratum : Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy: Erratum

enthalten in: Theranostics | 2021

von Yang, L. | Han, D. | Zhan, Q. | +14

ErratumFor: Theranostics. 2019 Oct 14;9(25):7680-7696. - PMID 31695794

5

Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy

enthalten in: Theranostics | 2020

von Zhan, Q. | Yi, K. | Qi, H. | +10

6

Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy

enthalten in: Theranostics | 2019

von Yang, L. | Han, D. | Zhan, Q. | +14

ErratumIn: Theranostics. 2021 Jan 1;11(4):1543-1545. - PMID 33408766

1
[1]